OYKU SENTURK
Manhattan/New York
Summary
Oyku Senturk, MD, BCMAS, is a distinguished medical professional with extensive experience spanning over 17 years in various leadership roles within the pharmaceutical and healthcare industry.
Currently serving as the Chief Medical Officer and Managing Director at Medicologist, he has an impressive track record of leading medical strategy, evaluating molecules, serving as a medical writer, providing scientific advisory services, and contributing to product launches in both national and international domains.
His Professional journey includes key positions such as Global Medical Affairs Director at IPSEN – France, where he led the strategic development of Dysport; Medical Director at Pharmactive – Turkey, successfully overseeing the medical affairs department; Sr. Medical Advisor at AMGEN – Turkey, where he managed biosimilar products; Head of Medical Affairs at Actavis Pharmaceuticals, receiving recognition awards; Neuroscience Regional/Research Scientific Services Manager at Allergan Pharmaceuticals; Medicomarketing Manager at Janssen-Cilag; and Product Manager at Bayer Schering Pharma.
Dr. Senturk has played a vital role in managing blockbuster drugs, launching new indications and products, developing clinical trial protocols, working closely with Key Opinion Leaders, and ensuring compliance with various regulations. He has also been instrumental in business development initiatives, managing cross-functional product teams, conducting medical training, and publishing noteworthy research.
His educational background includes a Medical Doctor Diploma from Istanbul University Cerrahpasa Medical Faculty, and he possesses an array of computer skills encompassing MS Office, Adobe Pro, Micromedex, and more. His exceptional leadership, strategic thinking, and dedication to the medical field have led to many successes and accolades throughout his career, solidifying her reputation as a leading figure in his field.
Overview
17
17
years of professional experience
Work History
Chief Medical Officer and Managing Director
Medicologist
05.2017 - Current
- Evaluated molecules/diseases including Caplacizumab in aTTP, Cerebral Tendinous Xanthomatosis, Laennec, Metyrapone in CS, Idebenone in LHON disease, and Siltuximab in MCD, providing medical rationale for country, scenarios of approval, patient pool, treatment centers, market potential, and forecasting.
- Served as medical writer and scientific advisor for Sanofi Academy, contributing to projects such as social media communication, trainings, and scientific advisory roles.
- Worked with Janssen as trainer and scientific advisor, participating in new molecule registration dossier preparation, launch preparations, strategic consultancy, and medical writing.
- Provided expertise as Abbott Veeva approver, contributing to social media communication projects, registration dossier preparation, and medical evaluation projects.
- Acted as advisory board medical writer and contributed to strategy development and local guideline medical writing for Boehringer Ingelheim, BioMarin
- Contributed to social media communication projects for Novonordisk's diabetes group.
- Acted as official consultant company for Turkish Neurology Society projects, successfully preparing dossiers for psychiatric drugs use in neurological indications, leading to favorable changes in reimbursement process. Completed Insomnia and Narcolepsy projects.
- Participated in launch readiness projects for various products.
- Conducted team medical and medico marketing training projects in Turkish and English languages.
- Contributed to successful peptide product launches for esthetics, osteoarthritis, and diabetes.
- Provided training for Nutricia TMEA team on AMN products.
- Edited and published book on Ketogenic Diet in children.
- Provided business development consultant services for new molecules and markets.
- Contributed to product launch preparations for various projects.
- Assisted in registration submission process for food supplements.
- Defined medical and administrative best practices in policies and procedures.
- Maintained compliance with local, national and federal requirements for staff education and certifications.
- Educated and mentored more than 2000 representatives.
Global Medical Affairs Director
IPSEN
06.2017 - 06.2018
- Led strategic development of Dysport, focusing on new indications, clinical trials, and overall therapeutic strategy from 2018 to 2022.
- Designed and authored Phase IV clinical trial protocol for Dysport use in Spasticity, ensuring comprehensive coverage of safety profiles.
- Established strong relationships with Key Opinion Leaders (KOLs) in short period of time, enhancing collaboration and support for Dysport initiatives.
- Provided Investigator-Initiated Study (IIS) support for KOLs and ensured timely submission for congresses, maximizing global impact of research.
- Developed KOL development program for therapeutic area, nurturing relationships and strengthening network of influential experts.
- Contributed to research and development strategy for Dysport's future, providing valuable input for ongoing innovation.
- Played crucial role in developing strategic and tactical plans for field deployment, ensuring effective implementation of Dysport initiatives.
- Planned and executed Advisory Board meetings, facilitating strategic discussions and guiding launch of Dysport in therapeutic area.
- Verified effective, consistent communication between department heads, medical staff and governing boards through board meeting attendance and synchronization of interdepartmental functions.
- Maintained compliance with local, national and federal requirements for staff education and certifications.
- Developed quarterly and yearly objectives, goals and budgets in addition to devising suggestions to decrease spending.
- Developed alliances with internal departments resulting in improved communication and performance throughout region.
- Monitored industry trends and advances in evidence-based medicine to purchase and utilize innovative equipment while maintaining operating budgets and expenditures.
Medical Director
Pharmactive
05.2016 - 02.2017
- Successfully built and led high-performing team in medical affairs department.
- Designed and implemented efficient workflow and processes for medical affairs department, enhancing productivity and collaboration.
- Oversaw medical affairs activities for all marketed products and those in pipeline, ensuring compliance and strategic alignment.
- Provided local and international support for product launches across multiple indications and disease areas, contributing to successful market entries.
- Played key role in supporting business development initiatives, including in-licensing original/generic and rare disease products, out-licensing pharmaceutical products, and engaging in co-development and co-marketing projects.
- Led successful launch of Air-Tide, Andorex, Nimokain, Gastren Duo, and Ibucold series, achieving market penetration and positive reception.
- Verified effective, consistent communication between department heads, medical staff and governing boards through board meeting attendance and synchronization of interdepartmental functions.
- Attended healthcare conferences to stay abreast of evolution of technology and implemented improvements in practice.
- Maintained compliance with local, national and federal requirements for staff education and certifications.
- Drove planning for business development and relationship building with healthcare partners.
- Oversaw and developed clinical departments through hiring, training and evaluating staff.
Sr. Medical Advisor
AMGEN
05.2015 - 05.2016
- Led Biosimilar Pipeline Products portfolio, denosumab, at AMGEN, overseeing development and strategic management of biosimilar products
- Successfully guided launch and market entry of Remsima, biosimilar product
- Served as Medical Affairs department head at Mustafa Nevzat, responsible for both promoted and non- promoted products
- Provided strategic direction and leadership to medical affairs team
- Successfully launched and managed Prolia, biologic product for treatment of osteoporosis, ensuring its effective positioning in market.
- Drafted and analyzed complex medical data.
- Established relationships with external customers to gain insights into decision-making and brand strategy development.
- Reviewed literature and facilitated discussion to develop and maintain product knowledge and expertise.
Medical Director
Mustafa Nevzat
05.2015 - 05.2016
- Led Biosimilar Pipeline Products portfolio at Mustafa Nevzat, overseeing development and strategic management of biosimilar products
- Successfully guided launch and market entry of Remsima, biosimilar product
- Served as Medical Affairs Director at Mustafa Nevzat, responsible for both promoted and non- promoted products
- Provided strategic direction and leadership to medical affairs team
- Drafted and analyzed complex medical data.
- Established relationships with external customers to gain insights into decision-making and brand strategy development.
- Reviewed literature and facilitated discussion to develop and maintain product knowledge and expertise.
Medical Director
Actavis
05.2013 - 05.2015
- "Best Actavis Of Year 2013" Award
- Verified effective, consistent communication between department heads, medical staff and governing boards through board meeting attendance and synchronization of interdepartmental functions.
- Attended healthcare conferences to stay abreast of evolution of technology and implemented improvements in practice.
- Maintained compliance with local, national and federal requirements for staff education and certifications.
- Developed quarterly and yearly objectives, goals and budgets in addition to devising suggestions to decrease spending.
- Drove planning for business development and relationship building with healthcare partners.
- Led successful Actavis Academy Launch, delivering basic medical training to field force and implementing online quiz system for enhanced learning. Project was recognized as Best Project and served as model for other Actavis Academy Launch countries.
- Ensured compliance with laws and regulations across various areas, including quality, clinical and regulatory affairs, conflicts of interest, gifts and entertainment, company records, confidential information, fair dealing, protection and use of company assets, political contributions and activities, antitrust and competition laws, improper payments, international trade compliance, environment, health and safety, employment practices, external inquiries, and representation on behalf of Actavis.
- Successfully created and published local SOPs, providing clear guidelines for compliance and facilitating efficient business processes.
- Provided effective leadership and strategic/operational direction to direct reports, offering coaching, and management support to foster their professional growth and development.
- Played pivotal role in driving successful implementation of Medical Affairs structure across business units, ensuring alignment and optimal utilization of resources.
- Conducted ongoing assessments of Medical Affairs resource needs, including headcount and budget, ensuring issues were recorded and reported as appropriate.
- Implemented individual development plans for each direct report, fostering their growth, and aligning their skills with organizational objectives.
- Oversaw and developed clinical departments through hiring, training and evaluating staff.
Regional Scientific Services (RSS) Manager
Allergan Pharmaceuticals
11.2010 - 05.2013
- "Best RSS of Europe Year 2011" Award
- Led successful approval of Chronic Migraine in Turkey, making it 3rd country in world (after US and UK) to receive approval. This approval also included patient population with "Medication Overuse Headache."
- Achieved fastest approval for NDO (Neurogenic Detrusor Overactivity) in Turkey, with process completed within just 4 days.
- Facilitated name change of OnabotulinumtoxinA in Turkey without WHO approvals, making it only country, after USA, to have this name change.
- Played vital role as member of EAME Medical Affairs Department, reporting to Medical Director, and ensuring that all activities and defined goals were aligned with Medical Affairs strategy and not linked to sales or sales targets.
- Oversaw and provided specialist scientific support to healthcare professionals (HCPs) and internal Allergan customers as non-promotional RSS Manager.
- Successfully launched new indications and products, organized and executed ad-boards, networks, workshop groups, governmental lobby activities, clinical trials, and guidelines, while effectively managing key opinion leaders (KOLs) and maintaining strong relationships with associations
- Built client relationships by responding to inquiries, identifying and assessing clients' needs, resolving problems, and following up with potential and existing clients.
- Interacted with clients on regular basis to quickly alleviate issues and provide project updates.
- Delivered outstanding service to clients to maintain and extend relationships for future business opportunities.
- Performed duties and provided service in accordance with established operating procedures and company policies.
- Scheduled and attended meetings with clients and prospective clients as requested.
- Developed new employees and on-going performance assessment of current employees.
- Built relationships with customers and community to establish long-term business growth.
- Resolved problems with high-profile customers to maintain relationships and increase return customer base.
Medicomarketing Manager
Janssen
05.2009 - 11.2010
- "Best Group Project 2010" Award
- Successfully managed Medical Affairs activities for blockbuster drug Risperdal Consta, contributing to its continued success in market.
- Played key role as member of cross-functional product team, consolidating strategies for therapeutic area and ensuring alignment with J&J's Code of Conduct, compliance rules, and ethical procedures.
- Collaborated with product managers to prepare medical content of promotional materials, ensuring scientific accuracy, compliance with HCBI policies, and consistency.
- Organized and coordinated medical educational programs, including training programs, national and international congress participation, stand-alone meetings, advocacy initiatives, and advisory board meetings, in alignment with strategic objectives. Evaluated effectiveness of these programs.
- Gathered scientific data on competitors' products to support product strategies and inform marketing activities, enabling informed decision-making.
- Managed and motivated employees to be productive and engaged in work.
- Accomplished multiple tasks within established timeframes.
- Maintained professional, organized, and safe environment for employees and patrons.
- Onboarded new employees with training and new hire documentation.
- Communicated clearly with employees, suppliers and stakeholders to keep everyone on same page and working toward established business goals.
- Controlled costs to keep business operating within budget and increase profits.
- Developed and implemented business strategies to achieve business goals and stay competitive.
Product Manager
Bayer Schering Pharma
05.2006 - 05.2009
- Successfully managed blockbuster drugs Angeliq, Climen, Climara, Primolut N, and Climodien, driving their market success through preparation of annual business plans, market objectives, strategies, and tactics
- Effectively allocated resources and presented at internal marketing meetings and international conferences
- Generated new market opportunities and developed innovative ideas to capitalize on them
- Handled internal and external challenges with care, and planned marketing strategies for new business opportunities, utilizing data and market research insights
- Established strong Key Opinion Leader (KOL) management, fostering experience sharing and attending relevant meetings
- Delivered impactful presentations to healthcare professionals on promoted drugs and effectively briefed agency partners to ensure aligned marketing efforts
- Monitored and analyzed results of promotional activities.
- Documented user stories, specifications, and product features into detailed work order to communicate across teams and build mandatory requirements.
- Communicated effectively with team members to deliver updates on project milestones and deadlines.
- Reviewed sales, customer concerns, and new opportunities to drive business strategy at weekly planning sessions.
- Collaborated with sales, marketing, and support teams to launch products on time and within budget.
- Analyzed metrics to measure product performance.
- Prioritized roadmap in order to achieve product goals and metrics.
Education
Medical DR Diploma -
Istanbul University, Cerrahpasa Medical Faculty
Istanbul06.2004
Skills
- Medical Expertise: Evaluation of molecules/diseases, product registration, clinical trials, medical writing, treatment strategies
- Pharmaceutical Management: Product launches, market penetration, strategic consultancy, biosimilar product management
- Research and Development: Clinical trial design, research strategy development, scientific support
- Compliance and Regulatory Affairs: Ensuring compliance with laws and regulations, creating and publishing local SOPs
- Training and Development: Conducting medical training, team development, coaching, and management support
- Marketing and Sales Strategy: Market research, KOL management, preparation of medical content for promotional materials, organizing and coordinating medical educational programs
- Leadership: Building and leading high-performing teams, strategic development, implementation of Medical Affairs structures
- Communication: Effective presentations, advisory board facilitation, successful collaboration with KOLs and healthcare professionals, and social media communication projects
- Strategic Planning: Planning and execution of strategic initiatives, tactical plans for field deployment, business development initiatives
- Problem Solving: Managing internal and external challenges, developing innovative ideas, and creating effective solutions
- Networking: Establishing strong relationships with key opinion leaders and influential experts in the field
Publications
- The prevalence and impact of primary headaches in orphaned children: a cross-sectional, observational study in a boarding school. https://doi.org/10.1080/17450128.2022.2073416
- Treatment frequency for long-term efficacy of abobotulinumtoxinA injections: A phase 3 study in patients with upper limb spasticity following stroke or traumatic brain injury. https://doi.org/10.1016/j.rehab.2018.05.845
- Management of Lower Urinary Tract Dysfunction in Multiple Sclerosis: A Systematic Review and Turkish Consensus Report. Neurourology and Urodynamics 32:1047–1057 (2013
Work Availability
monday
tuesday
wednesday
thursday
friday
saturday
sunday
morning
afternoon
evening
swipe to browse
Quote
Judge a man by his questions rather than his answers.
Voltaire
Timeline
Global Medical Affairs Director
IPSEN
06.2017 - 06.2018
Chief Medical Officer and Managing Director
Medicologist
05.2017 - Current
Medical Director
Pharmactive
05.2016 - 02.2017
Sr. Medical Advisor
AMGEN
05.2015 - 05.2016
Medical Director
Mustafa Nevzat
05.2015 - 05.2016
Medical Director
Actavis
05.2013 - 05.2015
Regional Scientific Services (RSS) Manager
Allergan Pharmaceuticals
11.2010 - 05.2013
Medicomarketing Manager
Janssen
05.2009 - 11.2010
Product Manager
Bayer Schering Pharma
05.2006 - 05.2009
Medical DR Diploma -
Istanbul University, Cerrahpasa Medical Faculty